ANI Pharmaceuticals price target raised to $62 from $60 at Truist
PremiumThe FlyANI Pharmaceuticals price target raised to $62 from $60 at Truist
22d ago
ANI Pharmaceuticals initiated with an Overweight at Piper Sandler
Premium
The Fly
ANI Pharmaceuticals initiated with an Overweight at Piper Sandler
1M ago
ANI Pharmaceuticals announces FDA approval, launch of Ketoconazole Shampoo, 2%
Premium
The Fly
ANI Pharmaceuticals announces FDA approval, launch of Ketoconazole Shampoo, 2%
2M ago
Salesforce downgraded, Charter upgraded: Wall Street’s top analyst calls
PremiumThe FlySalesforce downgraded, Charter upgraded: Wall Street’s top analyst calls
2M ago
ANI Pharmaceuticals, Alimera Sciences merger to close on September 16
Premium
The Fly
ANI Pharmaceuticals, Alimera Sciences merger to close on September 16
2M ago
ANI Pharmaceuticals downgraded to Hold from Buy at Truist
Premium
The Fly
ANI Pharmaceuticals downgraded to Hold from Buy at Truist
2M ago
ANI Pharmaceuticals reports Q2 adjusted EPS $1.02, consensus 95c
PremiumThe FlyANI Pharmaceuticals reports Q2 adjusted EPS $1.02, consensus 95c
3M ago
ANIP Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ANIP Upcoming Earnings Report: What to Expect?
3M ago
ANI Pharmaceuticals announces FDA approval, launch of L-Glutamine oral powder
Premium
The Fly
ANI Pharmaceuticals announces FDA approval, launch of L-Glutamine oral powder
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100